Literature DB >> 11447283

Somatic mosaicism in Wiskott--Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism.

T Wada1, S H Schurman, M Otsu, E K Garabedian, H D Ochs, D L Nelson, F Candotti.   

Abstract

Somatic mosaicism caused by in vivo reversion of inherited mutations has been described in several human genetic disorders. Back mutations resulting in restoration of wild-type sequences and second-site mutations leading to compensatory changes have been shown in mosaic individuals. In most cases, however, the precise genetic mechanisms underlying the reversion events have remained unclear, except for the few instances where crossing over or gene conversion have been demonstrated. Here, we report a patient affected with Wiskott--Aldrich syndrome (WAS) caused by a 6-bp insertion (ACGAGG) in the WAS protein gene, which abrogates protein expression. Somatic mosaicism was documented in this patient whose majority of T lymphocytes expressed nearly normal levels of WAS protein. These lymphocytes were found to lack the deleterious mutation and showed a selective growth advantage in vivo. Analysis of the sequence surrounding the mutation site showed that the 6-bp insertion followed a tandem repeat of the same six nucleotides. These findings strongly suggest that DNA polymerase slippage was the cause of the original germ-line insertion mutation in this family and that the same mechanism was responsible for its deletion in one of the propositus T cell progenitors, thus leading to reversion mosaicism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447283      PMCID: PMC37498          DOI: 10.1073/pnas.151260498

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance.

Authors:  J R Lo Ten Foe; M L Kwee; M A Rooimans; A B Oostra; A J Veerman; M van Weel; R M Pauli; N T Shahidi; I Dokal; I Roberts; C Altay; E Gluckman; R A Gibson; C G Mathew; F Arwert; H Joenje
Journal:  Eur J Hum Genet       Date:  1997 May-Jun       Impact factor: 4.246

2.  Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation.

Authors:  O Parolini; S Berardelli; E Riedl; C Bello-Fernandez; H Strobl; O Majdic; W Knapp
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

Review 3.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion.

Authors:  M F Jonkman; H Scheffer; R Stulp; H H Pas; M Nijenhuis; K Heeres; K Owaribe; L Pulkkinen; J Uitto
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

5.  Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia.

Authors:  W Zeng; S Nakao; H Takamatsu; A Yachie; A Takami; Y Kondo; N Sugimori; H Yamazaki; Y Miura; S Shiobara; T Matsuda
Journal:  Blood       Date:  1999-05-01       Impact factor: 22.113

Review 6.  The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.

Authors:  S B Snapper; F S Rosen
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

7.  Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation.

Authors:  T N Darling; C Yee; J W Bauer; H Hintner; K B Yancey
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

8.  Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency.

Authors:  R Hirschhorn; D R Yang; J M Puck; M L Huie; C K Jiang; L E Kurlandsky
Journal:  Nat Genet       Date:  1996-07       Impact factor: 38.330

9.  Mutation analysis of five Japanese families with Wiskott-Aldrich syndrome and determination of the family members' carrier status using three different methods.

Authors:  T Ariga; M Yamada; Y Sakiyama
Journal:  Pediatr Res       Date:  1997-04       Impact factor: 3.756

10.  Studies of the expression of the Wiskott-Aldrich syndrome protein.

Authors:  D M Stewart; S Treiber-Held; C C Kurman; F Facchetti; L D Notarangelo; D L Nelson
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

View more
  39 in total

Review 1.  Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways.

Authors:  Fabio Candotti; Luigi Notarangelo; Roberta Visconti; John O'Shea
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  Revertant mosaicism in skin: natural gene therapy.

Authors:  Joey E Lai-Cheong; John A McGrath; Jouni Uitto
Journal:  Trends Mol Med       Date:  2010-12-29       Impact factor: 11.951

3.  Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.

Authors:  Makoto Otsu; Masafumi Yamada; Satoru Nakajima; Miyuki Kida; Yoshihiro Maeyama; Norikazu Hatano; Nariaki Toita; Shunichiro Takezaki; Yuka Okura; Ryoji Kobayashi; Yoshinori Matsumoto; Osamu Tatsuzawa; Fumiko Tsuchida; Shunichi Kato; Masanari Kitagawa; Junichi Mineno; Michael S Hershfield; Pawan Bali; Fabio Candotti; Masafumi Onodera; Nobuaki Kawamura; Yukio Sakiyama; Tadashi Ariga
Journal:  J Clin Immunol       Date:  2015-04-15       Impact factor: 8.317

Review 4.  Survival of the fittest: in vivo selection and stem cell gene therapy.

Authors:  Tobias Neff; Brian C Beard; Hans-Peter Kiem
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

5.  Analysis of T cell receptor Vbeta diversity in peripheral CD4 and CD8 T lymphocytes in patients with autoimmune thyroid diseases.

Authors:  M Okajima; T Wada; M Nishida; T Yokoyama; Y Nakayama; Y Hashida; F Shibata; Y Tone; A Ishizaki; M Shimizu; T Saito; K Ohta; T Toma; A Yachie
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

6.  Decreased expression in nuclear factor-κB essential modulator due to a novel splice-site mutation causes X-linked ectodermal dysplasia with immunodeficiency.

Authors:  Shuhei Karakawa; Satoshi Okada; Miyuki Tsumura; Yoko Mizoguchi; Norioki Ohno; Shin'ichiro Yasunaga; Motoaki Ohtsubo; Tomoki Kawai; Ryuta Nishikomori; Takemasa Sakaguchi; Yoshihiro Takihara; Masao Kobayashi
Journal:  J Clin Immunol       Date:  2011-07-01       Impact factor: 8.317

7.  Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1).

Authors:  Gulbu Uzel; Emilia Tng; Sergio D Rosenzweig; Amy P Hsu; Jacqueline M Shaw; Mitchell E Horwitz; Gilda F Linton; Stacie M Anderson; Martha R Kirby; Jaõ B Oliveira; Margaret R Brown; Thomas A Fleisher; S K Alex Law; Steven M Holland
Journal:  Blood       Date:  2007-09-17       Impact factor: 22.113

8.  Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.

Authors:  Taizo Wada; Akihiro Konno; Shepherd H Schurman; Elizabeth K Garabedian; Stacie M Anderson; Martha Kirby; David L Nelson; Fabio Candotti
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 9.  In vivo reversion to normal of inherited mutations in humans.

Authors:  R Hirschhorn
Journal:  J Med Genet       Date:  2003-10       Impact factor: 6.318

10.  Clonal expansion of Epstein-Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions.

Authors:  Taizo Wada; Akiko Toga; Yasuhisa Sakakibara; Tomoko Toma; Minoru Hasegawa; Kazuhiko Takehara; Tomonari Shigemura; Kazunaga Agematsu; Akihiro Yachie
Journal:  Int J Hematol       Date:  2012-08-12       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.